ARCUTIS BIOTHERAPEUTICS INC (ARQT) Forecast, Price Target & Analyst Ratings

NASDAQ:ARQT • US03969K1088

Current stock price

24.61 USD
+1.34 (+5.76%)
At close:
24.7 USD
+0.09 (+0.37%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ARCUTIS BIOTHERAPEUTICS INC (ARQT).

Forecast Snapshot

Consensus Price Target

Price Target
$35.70
+ 45.06% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.06
Revenue Estimate
103.29M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$35.70
Upside
+ 45.06%
From current price of $24.61 to mean target of $35.70, Based on 14 analyst forecasts
Low
$33.33
Median
$35.70
High
$38.85

Price Target Revisions

1 Month
10.24%
3 Months
10.67%

Price Target Summary

14 Wall Street analysts provided a forecast for the next 12 months for ARQT. The average price target is 35.7 USD. This implies a price increase of 45.06% is expected in the next year compared to the current price of 24.61.
The average price target has been revised upward by 10.67% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ARQT Current Analyst RatingARQT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

ARQT Historical Analyst RatingsARQT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
ARQT was analyzed by 14 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ARQT.
In the previous month the buy percentage consensus was at a similar level.
ARQT was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-02MizuhoMaintains Outperform -> Outperform
2026-02-27GuggenheimMaintains Buy -> Buy
2026-02-26TD CowenMaintains Buy -> Buy
2026-02-26NeedhamMaintains Buy -> Buy
2026-02-26HC Wainwright & Co.Maintains Buy -> Buy
2026-01-26NeedhamMaintains Buy -> Buy
2025-11-28MizuhoMaintains Outperform -> Outperform
2025-10-30Goldman SachsMaintains Neutral -> Neutral
2025-10-28NeedhamMaintains Buy -> Buy
2025-08-07NeedhamMaintains Buy -> Buy
2025-07-25Goldman SachsInitiate Neutral
2025-05-23NeedhamReiterate Buy -> Buy
2025-04-09NeedhamReiterate Buy -> Buy
2025-04-03GuggenheimReiterate Buy -> Buy
2025-04-03NeedhamReiterate Buy -> Buy
2025-04-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-11JefferiesMaintains Buy -> Buy
2025-02-27Goldman SachsMaintains Neutral -> Neutral
2025-02-26MizuhoMaintains Outperform -> Outperform
2025-02-26NeedhamReiterate Buy -> Buy
2025-02-26HC Wainwright & Co.Reiterate Buy -> Buy
2025-02-24GuggenheimReiterate Buy -> Buy
2025-02-10GuggenheimReiterate Buy -> Buy
2025-01-13HC Wainwright & Co.Reiterate Buy -> Buy
2025-01-07MizuhoMaintains Outperform -> Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 4, 2026
Period
Q1 / 2026
EPS Estimate
-$0.06
Revenue Estimate
103.29M
Revenue Q2Q
56.87%
EPS Q2Q
70.78%
Number of Analysts
10

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
3.09%
EPS (1 Month)
-273.71%
EPS (3 Months)
-472.90%

Next Earnings Summary

ARQT is expected to report earnings on 5/4/2026. The consensus EPS estimate for the next earnings is -0.06 USD and the consensus revenue estimate is 103.29M USD.
The next earnings revenue estimate has been revised upward by 3.09% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ARQT revenue by date.ARQT revenue by date.
59.606M
1,515.34%		196.542M
229.74%		376.072M
91.34%		505.67M
34.46%		656.2M
29.77%		798.54M
21.69%		938.96M
17.58%		1.063B
13.21%		1.215B
14.30%		1.332B
9.63%		1.384B
3.90%
EBITDA
YoY % growth
ARQT ebitda by date.ARQT ebitda by date.
-239.58M
20.33%		-125.798M
47.49%		-7.56M
93.99%		88.929M
1,276.31%		194.88M
119.14%		305.59M
56.81%		321.5M
5.21%		400.76M
24.65%		494.8M
23.47%		N/AN/A
EBIT
YoY % growth
ARQT ebit by date.ARQT ebit by date.
-241.101M
20.07%		-128.397M
46.75%		-12.227M
90.48%		51.942M
524.81%		165.45M
218.53%		287.63M
73.85%		392.48M
36.45%		508.96M
29.68%		642.11M
26.16%		747.75M
16.45%		810.32M
8.37%
Operating Margin
ARQT operating margin by date.ARQT operating margin by date.
-404.49%-65.33%-3.25%10.27%25.21%36.02%41.80%47.88%52.85%56.14%58.55%
EPS
YoY % growth
ARQT eps by date.ARQT eps by date.
-3.92
30.62%		-1.16
70.41%		-0.14
87.93%		0.32
328.65%		1.20
274.91%		2.03
69.47%		2.79
37.42%		3.15
12.70%		3.68
16.84%		4.26
15.85%		4.37
2.45%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.06
70.78%		0.05
134.97%		0.11
87.73%		0.24
83.04%		0.06
204.73%		0.15
236.55%		0.22
99.22%		0.30
24.31%
Revenue
Q2Q % growth		103.29M
56.87%		117.55M
44.23%		130.19M
31.21%		154.3M
19.15%		140.76M
36.28%		157.08M
33.63%		171.36M
31.62%		185.64M
20.31%
EBITDA
Q2Q % growth		8.551M
139.96%		15.643M
241.32%		31.366M
148.35%		51.199M
122.08%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-8.5M
65.35%		6.783M
146.42%		14.79M
73.47%		35.421M
92.64%		9.894M
216.40%		23.052M
239.85%		34.374M
132.41%		45.696M
29.01%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ARQT Yearly Revenue VS EstimatesARQT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
ARQT Yearly EPS VS EstimatesARQT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -10 -20

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
154.72%
EPS Next 5 Year
89.60%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
29.56%
Revenue Next 5 Year
23.69%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
165.68%
EBIT Next 5 Year
88.77%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ARCUTIS BIOTHERAPEUTICS INC / ARQT Forecast FAQ

What is the average price target for ARCUTIS BIOTHERAPEUTICS INC (ARQT) stock?

14 analysts have analysed ARQT and the average price target is 35.7 USD. This implies a price increase of 45.06% is expected in the next year compared to the current price of 24.61.

What is the next earnings date for ARQT stock?

ARCUTIS BIOTHERAPEUTICS INC (ARQT) will report earnings on 2026-05-04.

What are the consensus estimates for ARCUTIS BIOTHERAPEUTICS INC (ARQT) next earnings?

The consensus EPS estimate for the next earnings of ARCUTIS BIOTHERAPEUTICS INC (ARQT) is -0.06 USD and the consensus revenue estimate is 103.29M USD.

Can you provide the analyst count for ARCUTIS BIOTHERAPEUTICS INC stock?

The number of analysts covering ARCUTIS BIOTHERAPEUTICS INC (ARQT) is 14.